Ming-feng Chiang

Yilan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Angiotensin-Converting Enzyme Inhibitors and Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis B and Hypertension: A Nationwide Dose-Response Cohort Study.

Angiotensin-Converting Enzyme Inhibitors and Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis B and Hypertension: A Nationwide Dose-Response Cohort Study.

Journal: Clinical and translational gastroenterology

Published: March 12, 2026

Taiwan Academy of Tumor Ablation (TATA) consensus on hepatocellular carcinoma ablation.

Taiwan Academy of Tumor Ablation (TATA) consensus on hepatocellular carcinoma ablation.

Journal: Hepatology international

Published: September 30, 2025

Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor Ablation.

Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor Ablation.

Journal: Liver cancer

Published: February 04, 2025

Preclinical Pharmacokinetic, Pharmacodynamic, and Safety Profile of OBI-992: A Novel TROP2-Targeted Antibody-Drug Conjugate.

Preclinical Pharmacokinetic, Pharmacodynamic, and Safety Profile of OBI-992: A Novel TROP2-Targeted Antibody-Drug Conjugate.

Journal: Molecular cancer therapeutics

Published: December 14, 2024

OBI-992, a Novel TROP2-Targeted Antibody-Drug Conjugate, Demonstrates Antitumor Activity in Multiple Cancer Models.

OBI-992, a Novel TROP2-Targeted Antibody-Drug Conjugate, Demonstrates Antitumor Activity in Multiple Cancer Models.

Journal: Molecular cancer therapeutics

Published: July 17, 2024

Protective effect of N-acetylcysteine against hepatocellular carcinoma in hepatitis B virus carriers.

Protective effect of N-acetylcysteine against hepatocellular carcinoma in hepatitis B virus carriers.

Journal: American journal of cancer research

Published: May 11, 2024

Survival impact of pre-transplant local treatments in liver transplant recipients with BCLC stage A hepatocellular carcinoma.

Survival impact of pre-transplant local treatments in liver transplant recipients with BCLC stage A hepatocellular carcinoma.

Journal: American journal of cancer research

Published: May 08, 2024

Effects of N-acetylcysteine on hepatocellular carcinoma in chronic hepatitis C.

Effects of N-acetylcysteine on hepatocellular carcinoma in chronic hepatitis C.

Journal: American journal of cancer research

Published: May 07, 2024

Protective effects of statins on the incidence of NAFLD-related decompensated cirrhosis in T2DM.

Protective effects of statins on the incidence of NAFLD-related decompensated cirrhosis in T2DM.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: March 08, 2023

SENP2 restrains the generation of pathogenic Th17 cells in mouse models of colitis.

SENP2 restrains the generation of pathogenic Th17 cells in mouse models of colitis.

Journal: Communications biology

Published: September 03, 2022

Effects of H1-Antihistamines on hepatocellular carcinoma risk in patients with type 2 diabetes mellitus.

Effects of H1-Antihistamines on hepatocellular carcinoma risk in patients with type 2 diabetes mellitus.

Journal: Diabetes & metabolism

Published: July 19, 2022

A Novel Predictive Scoring System for 90-Day Mortality among Patients with Hepatocellular Cell Carcinoma Receiving Major Hepatectomy.

A Novel Predictive Scoring System for 90-Day Mortality among Patients with Hepatocellular Cell Carcinoma Receiving Major Hepatectomy.

Journal: Cancers

Published: February 13, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026